基因编辑重塑医药:精准应用、技术挑战与伦理突破
医学与健康科学研究 · 30.04.2026 · 2 (2) · 37-41
DOI: 10.65196/h8vaas23 ↗Kurz gefasst
Fachartikel in der Zeitschrift 医学与健康科学研究, online erschienen am 30.04.2026. Verfasst von 亚黎 周 und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
As a revolutionary breakthrough in the field of life sciences, gene editing technology is profoundly reshaping the landscape of medical and pharmaceutical research. This paper systematically explains the molecular mechanisms of gene editing technology, with a particular focus on its application value in core areas such as the construction of precise disease models, the development of innovative gene therapies, targeted drug discovery, and xenotransplantation. It also deepens the analysis of these application scenarios in light of the latest clinical research findings from 2024 to 2025. At the same time, the paper thoroughly explores key challenges in the application of this technology, including off-target effects, immunogenicity, and ethical controversies. It further reviews in detail the current progress in technological optimization strategies and the development of ethical regulatory systems, and proposes future pathways for the coordinated advancement of technological innovation and ethical governance, with the aim of providing more comprehensive theoretical support and practical guidance for the standardized clinical translation of gene editing technology.
Zitieren
APA
周, 亚., & 张, 凯. (2026). 基因编辑重塑医药:精准应用、技术挑战与伦理突破. 医学与健康科学研究, 2(2), 37-41. https://doi.org/10.65196/h8vaas23
Vancouver
周 亚, 张 凯. 基因编辑重塑医药:精准应用、技术挑战与伦理突破. 医学与健康科学研究. 2026;2(2):37-41. doi:10.65196/h8vaas23
BibTeX
@article{2026,
author = {周, 亚黎 and 张, 凯博},
title = {基因编辑重塑医药:精准应用、技术挑战与伦理突破},
journal = {医学与健康科学研究},
year = {2026},
volume = {2},
number = {2},
pages = {37--41},
doi = {10.65196/h8vaas23}
}
EUVIMED